Sequence-defined phosphoestamers for selective inhibition of the KRASG12D/RAF1 interaction
2025

New Molecules to Block Cancer Growth

publication Evidence: high

Author Information

Author(s): Claringbold Bini, Vance Steven, Paul Alexandra R., Williamson James, Garrett Michelle D., Serpell Christopher J.

Primary Institution: University of Kent

Hypothesis

Can synthetic phosphoestamers selectively inhibit the KRASG12D/RAF1 interaction?

Conclusion

The study identified six novel phosphoestamers that effectively inhibit the KRASG12D/RAF1 interaction, with some showing high selectivity for the mutant form over the wild type.

Supporting Evidence

  • The phosphoestamers showed IC50 values as low as 25 nM against KRASG12D.
  • Three phosphoestamers were selective for the mutant KRASG12D over the wild type.
  • The study provides proof-of-concept for using phosphoestamers to target protein-protein interactions.

Takeaway

Scientists created new molecules that can stop cancer cells from growing by blocking a specific interaction that helps them grow.

Methodology

The study used a library of synthetic phosphoestamers and selected those that inhibit the KRASG12D/RAF1 interaction through fluorescence-activated bead sorting.

Limitations

The pharmacokinetic challenges associated with large, polyanionic compounds may limit their effectiveness as drugs.

Digital Object Identifier (DOI)

10.1039/d4sc07218a

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication